  |
  ![[help]](/images/buttons/help.gif)
|
|
|
|
|
|
| 1998 - present | A comparison of the long term efficacy of self-help weight loss versus a commercial weight loss program. Weight Watchers International. |
| 1995 - present | A randomized, double-blind, placebo-controlled, studies to evaluate the safety, tolerability and efficacy of a recombinant genetically-derived protein in subjects across a range of body mass indexes. Amgen |
| 1997 - present | A randomized clinical trial of a novel device for increasing physical activity and reducing television viewing in obese children. National Institutes of Health. |
| 1998 - 1999 | A 52 week double-blind, randomized, placeb-controlled multicenter trial to evaluate the efficacy of Orlistat plus diet in obese hypertensive patients inadequately controlled with antihypertensive medications. Hoffman-LaRoche |
| 1994 - 1999 | The effect of weight loss on bone turnover in pre and post menopausal women. National Institutes of Health |
| 1998 - 1999 | Treatment of exogenous obesity by Pot11, a natural cholycystokinen enhancer. Pacific Health Laboratories Inc. |
| 1997 - 1999 | The safety and efficacy of an herbal preparation: Ephedrine and caffeine for treatment of obesity: A double-blind study. Science, Toxicology, and Technology. |
| 1997 - 1999 | The treatment of moderate obesity with an herbal preparation containing ephedrine and caffeine: A double-blind study. Science, Toxicology, and Technology. |
| 1996 - 1998 | St. John's wort and ephedra for weight loss. NutriSystems, Inc. |
| 1996 - 1997 | A randomized placebo-controlled trial of Garcinia Cambogia. Thompson Pharmaceutical |
| 1993 - 1994 | A randomized, placebo-controlled clinical trial of an acupressure device for weight loss. Original Marketing, Inc. |
| 1992 - 1993 | Safety and efficacy of a new meal replacement product. Campbells Soups |
| 1992 - 1994 | A 108 week study of the effect of Orlistat in the treatment of obesity with dietary counseling. HoffmannLaRoche Inc. |
| 1991 - 1992 | Effects of recombinant human insulinlike growth factor I (rhIGFI) on body weight and composition in obese subjects. CIBA-GEIGY |
| 1990 - 1991 | The effect of tetrahydrolipstatin on weight loss in patients with moderate and severe upper-body obesity after 12 weeks of therapy. Hoffman-La Roche Inc. |
| 1989 - 1991 | A double-blind, placebo controlled pilot study to evaluate the weight reducing and anorectic activity and safety of Sibutramine Hydrochloride 10mg per day in obese subjects. The Boots Company (USA) |
| 1985 - 1989 | Therapeutic benefit of dexfenfluramine on body composition and weight loss after three months of treatment in obese outpatients. Institut de Recherches International Servier |